Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab
出版年份 2018 全文链接
标题
Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab
作者
关键词
-
出版物
ACTA ONCOLOGICA
Volume -, Issue -, Pages 1-7
出版商
Informa UK Limited
发表日期
2018-04-24
DOI
10.1080/0284186x.2018.1465585
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project
- (2017) Fred R. Hirsch et al. Journal of Thoracic Oncology
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Real-world data on nivolumab treatment of non-small cell lung cancer
- (2016) O.T. Brustugun et al. ACTA ONCOLOGICA
- A pooled analysis of nivolumab for the treatment of advanced non-small-cell lung cancer and the role of PD-L1 as a predictive biomarker
- (2016) Pedro N Aguiar et al. Immunotherapy
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Comprehensive Circular RNA Profiling Reveals That hsa_circ_0005075, a New Circular RNA Biomarker, Is Involved in Hepatocellular Crcinoma Development
- (2016) Xingchen Shang et al. MEDICINE
- miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4
- (2016) Lifen Zhao et al. ONCOLOGY REPORTS
- Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer
- (2016) Xu Chen et al. TUMOR BIOLOGY
- miR-494-3p is a novel tumor driver of lung carcinogenesis
- (2016) Alice Faversani et al. Oncotarget
- A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer
- (2016) Ann Rita Halvorsen et al. Oncotarget
- PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?
- (2016) Claud Grigg et al. Journal for ImmunoTherapy of Cancer
- MicroRNA Targeting to Modulate Tumor Microenvironment
- (2016) Praneeth R. Kuninty et al. Frontiers in Oncology
- Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art?
- (2015) Keith M. Kerr et al. Journal of Thoracic Oncology
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- miR-215 functions as a tumor suppressor and directly targets ZEB2 in human non-small cell lung cancer
- (2015) YAN HOU et al. Oncology Letters
- Tumor Interstitial Fluid Formation, Characterization, and Clinical Implications
- (2015) Marek Wagner et al. Frontiers in Oncology
- Building Predictive Models inRUsing thecaretPackage
- (2015) Max Kuhn Journal of Statistical Software
- Regularization Paths for Generalized Linear Models via Coordinate Descent
- (2015) Jerome Friedman et al. Journal of Statistical Software
- Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma
- (2014) David McDermott et al. CANCER TREATMENT REVIEWS
- Circulating MicroRNA Biomarker Studies: Pitfalls and Potential Solutions
- (2014) K. W. Witwer CLINICAL CHEMISTRY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Methodological challenges in utilizing miRNAs as circulating biomarkers
- (2014) Leni Moldovan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MicroRNA regulons in tumor microenvironment
- (2014) H I Suzuki et al. ONCOGENE
- Assessing sample and miRNA profile quality in serum and plasma or other biofluids
- (2012) Thorarinn Blondal et al. METHODS
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-λ1
- (2012) Yongkui Li et al. Protein & Cell
- survcomp: an R/Bioconductor package for performance assessment and comparison of survival models
- (2011) Markus S. Schröder et al. BIOINFORMATICS
- pROC: an open-source package for R and S+ to analyze and compare ROC curves
- (2011) Xavier Robin et al. BMC BIOINFORMATICS
- Prognostic Significance of miR-215 in Colon Cancer
- (2011) Mihriban Karaayvaz et al. Clinical Colorectal Cancer
- Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
- (2011) Radha Duttagupta et al. PLoS One
- Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
- (2008) S. A. Georges et al. CANCER RESEARCH
- The impact of microRNAs on protein output
- (2008) Daehyun Baek et al. NATURE
- Lung Cancer
- (2008) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started